They are basically where we were 60 days ago with some nice anecdotal results from a small group. That tells me they likely have something that's working, but it will be curious to see how quickly they progress as compared to CYDY. I'll also be interested to learn more about their drug and the side effects. The absence of SAE in 800+ patients continues to be a huge part of the Leronlimab story.